Singapore boosts its medical technology R&D (research and development) drive:
This article was originally published in Clinica
Executive Summary
Singapore hopes to boost local medtech research and development with the launch of a new scheme, the Medtech Concept Initiative. The Economic Development Board's biomedical sciences group (BMSG) has partnered with Nanyang Polytechnic (NP) to build upon the 2003 BMSG's proof-of-concept (POC) initiative. This encouraged projects that showed promise of developing into start-up businesses by providing them with research funding of up to S$300,000 (US$ 177,000). In addition to these funds, eligible projects under the new scheme will benefit from NP's existing infrastructure and resources.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.